Latest & greatest articles for folic acid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on folic acid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on folic acid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for folic acid

41. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force.

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. BACKGROUND: Neural tube defects (NTDs) are among the most common birth defects in the United States. In 1996, the U.S. Preventive Services Task Force (USPSTF) recommended that all women planning a pregnancy or capable of conception take a supplement containing folic acid to reduce the risk for NTDs. PURPOSE: To search for new evidence published since 1996 (...) on the benefits and harms of folic acid supplementation for women of childbearing age to prevent neural tube defects in offspring, to inform an updated USPSTF recommendation. DATA SOURCES: MEDLINE and Cochrane Central Register of Controlled Trials searches from January 1995 through December 2008, recent systematic reviews, reference lists of retrieved articles, and expert suggestions. STUDY SELECTION: English-language randomized, controlled trials; cohort studies; case-control studies; systematic reviews

Annals of Internal Medicine2009

42. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement.

Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. DESCRIPTION: In 1996, the U.S. Preventive Services Task Force (USPSTF) recommended that all women planning or capable of pregnancy take a multivitamin supplement containing folic acid for the prevention of neural tube defects. This recommendation is an update of the 1996 USPSTF recommendation. METHODS: The USPSTF reviewed the evidence on folic acid supplementation in women (...) of childbearing age published since the 1996 USPSTF recommendation. The USPSTF did not review the evidence on folic acid food fortification, counseling to increase dietary intake, or screening for neural tube defects. RECOMMENDATION: The USPSTF recommends that all women planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 microg) of folic acid. (Grade A recommendation).

Annals of Internal Medicine2009

43. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies.

Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't

Society of Obstetricians and Gynaecologists of Canada2009

44. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Wolff T, Witkop CT, Miller T, Syed SB Record Status This is a bibliographic (...) record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Wolff T, Witkop CT, Miller T, Syed SB. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No 70. 2009 Authors' objectives To update the evidence on folic acid

Health Technology Assessment (HTA) Database.2009

45. Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Asse

Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Asse Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics (...) and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ

DARE.2009

46. High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials

High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled (...) clinical trials McRae MP CRD summary This review concluded that supplementation with at least 5,000μg of folic acid per day, for at least six weeks, could lower blood pressure slightly, but real clinical benefit was achieved through improved endothelial function. This conclusion reflected the results, but multiple issues with the conduct and reporting of the review mean that its reliability is unclear. Authors' objectives To assess the effect of high-dose folic acid supplementation on blood

DARE.2009

47. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review

Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review Prey S, Paul C CRD summary This review assessed the efficacy of folic acid (...) supplementation in patients receiving methotrexate for inflammatory diseases, concluding that was an effective measure to reduce hepatic side-effects associated with methotrexate treatment. However, given the small number of included studies of uncertain quality, the authors' conclusions should be interpreted with caution. Authors' objectives To assess the efficacy of folic acid supplementation in patients receiving methotrexate treatment for inflammatory diseases. Searching MEDLINE, EMBASE, Cochrane Skin

DARE.2009

48. Cancer incidence and mortality after treatment with folic acid and vitamin B12.

Cancer incidence and mortality after treatment with folic acid and vitamin B12. 19920236 2009 11 20 2009 11 30 2016 10 17 1538-3598 302 19 2009 Nov 18 JAMA JAMA Cancer incidence and mortality after treatment with folic acid and vitamin B12. 2119-26 10.1001/jama.2009.1622 Recently, concern has been raised about the safety of folic acid, particularly in relation to cancer risk. To evaluate effects of treatment with B vitamins on cancer outcomes and all-cause mortality in 2 randomized controlled (...) trials. Combined analysis and extended follow-up of participants from 2 randomized, double-blind, placebo-controlled clinical trials (Norwegian Vitamin Trial and Western Norway B Vitamin Intervention Trial). A total of 6837 patients with ischemic heart disease were treated with B vitamins or placebo between 1998 and 2005, and were followed up through December 31, 2007. Oral treatment with folic acid (0.8 mg/d) plus vitamin B(12) (0.4 mg/d) and vitamin B(6) (40 mg/d) (n = 1708); folic acid (0.8 mg/d

JAMA2009

49. Management issues for women with epilepsy-focus on pregnancy: vitamin k, folic acid, blood levels, and breastfeeding

Management issues for women with epilepsy-focus on pregnancy: vitamin k, folic acid, blood levels, and breastfeeding Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share July 14, 2009 ; 73 (2) Special (...) Article Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society C. L. Harden , P. B. Pennell , B. S. Koppel , C. A. Hovinga , B. Gidal , K. J. Meador , J. Hopp , T. Y. Ting , W. A. Hauser , D. Thurman , P. W. Kaplan , J. N

American Academy of Neurology2009

50. Practice Parameter update: Managment issues for women with epilepsy - Focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding

Practice Parameter update: Managment issues for women with epilepsy - Focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding DOI 10.1212/WNL.0b013e3181a6b325 2009;73;142-149 Published Online before print April 27, 2009 Neurology C. L. Harden, P. B. Pennell, B. S. Koppel, et al. of Neurology and American Epilepsy Society Technology Assessment Subcommittee of the American Academy the Quality Standards Subcommittee and Therapeutics and Vitamin K, folic acid, blood levels (...) , MD J. Hopp, MD T.Y. Ting, MD W.A. Hauser, MD D.Thurman,MD,MPH P.W.Kaplan,MB,FRCP J.N. Robinson, MD J.A. French, MD S. Wiebe, MD A.N. Wilner, MD B. Vazquez, MD L. Holmes, MD A. Krumholz, MD R. Finnell, PhD P.O. Shafer, RN, MN C. Le Guen ABSTRACT Objective:To reassess the evidence for management issues related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid use, prenatal vitamin K use, risk of hemorrhagic disease of the newborn, clinical implications

American Epilepsy Society2009

51. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.

Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. BACKGROUND: Folate deficiency can result in congenital neural tube defects and megaloblastic anaemia. Low folate levels may be due to insufficient dietary intake or inefficient absorption, but impaired metabolic utilization also occurs.Because B12 deficiency can produce a similar anaemia to folate deficiency, there is a risk that folate supplementation can delay the diagnosis of B12 (...) deficiency, which can cause irreversible neurological damage. Folic acid supplements may sometimes therefore include vitamin B12 supplements with simultaneous administration of vitamin B12.Lesser degrees of folate inadequacy are associated with high blood levels of the amino acid homocysteine which has been linked with the risk of arterial disease, dementia and Alzheimer's disease. There is therefore interest in whether dietary supplementation can improve cognitive function in the elderly.However, any

Cochrane2008

52. Daily folic acid supplementation for 3 years reduced age related hearing loss

Daily folic acid supplementation for 3 years reduced age related hearing loss Daily folic acid supplementation for 3 years reduced age related hearing loss | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword (...) Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily folic acid supplementation for 3 years reduced age related hearing loss Article Text Treatment Daily folic acid supplementation for 3 years reduced age related hearing loss Statistics from Altmetric.com No Altmetric data available for this article. Request permissions If you wish to reuse any or all

Evidence-Based Nursing (Requires free registration)2008

53. Daily folic acid supplementation for 3 years improved cognitive function in older persons

Daily folic acid supplementation for 3 years improved cognitive function in older persons Daily folic acid supplementation for 3 years improved cognitive function in older persons | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search (...) for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily folic acid supplementation for 3 years improved cognitive function in older persons Article Text Therapeutics Daily folic acid supplementation for 3 years improved cognitive function in older persons Statistics from Altmetric.com No Altmetric data available for this article. Request permissions If you wish to reuse

Evidence-Based Medicine (Requires free registration)2008

54. Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people

Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people Article Text Therapeutics Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people Statistics from

Evidence-Based Medicine (Requires free registration)2008

55. Aspirin and folic acid for the prevention of recurrent colorectal adenomas

Aspirin and folic acid for the prevention of recurrent colorectal adenomas 18022173 2008 01 01 2008 02 05 2013 11 21 1528-0012 134 1 2008 Jan Gastroenterology Gastroenterology Aspirin and folic acid for the prevention of recurrent colorectal adenomas. 29-38 Although observational studies have found regular aspirin use to be associated with a reduced risk of colorectal neoplasia, results from randomized trials using aspirin have been inconsistent. Dietary folate intake also has been found (...) to be associated with a reduced risk of colorectal neoplasms in observational studies. A multicenter, randomized, double-blind trial of aspirin (300 mg/day) and folate supplements (0.5 mg/day) to prevent colorectal adenoma recurrence was performed using a 2 x 2 factorial design. All patients had an adenoma (>/=0.5 cm) removed in the 6 months before recruitment and were followed-up at 4-month intervals with a second colonoscopy after approximately 3 years. The primary outcome measure was a colorectal adenoma

EvidenceUpdates2008

56. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy

A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy Chivu CM, Tulchinsky TH, Soares-Weiser K, Braunstein R, Brezis M CRD summary The authors concluded that interventions (...) to increase awareness, knowledge and consumption had a positive effect on folic acid intakes before and during pregnancy, although average usage reported was less than 25%. The authors discussed the limitations of the mostly retrospective evidence, but poor reporting of the review methods and study details limit the reliability of this review. Authors' objectives To assess the effects of interventions to increase awareness, knowledge and folic acid consumption before and during pregnancy. Searching

DARE.2008

58. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. 18460663 2008 05 07 2008 05 09 2016 12 15 1538-3598 299 17 2008 May 07 JAMA JAMA Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. 2027-36 10.1001/jama.299.17.2027 Recent randomized trials among patients with preexisting (...) cardiovascular disease (CVD) have failed to support benefits of B-vitamin supplementation on cardiovascular risk. Observational data suggest benefits may be greater among women, yet women have been underrepresented in published randomized trials. To test whether a combination of folic acid, vitamin B6, and vitamin B12 lowers risk of CVD among high-risk women with and without CVD. Within an ongoing randomized trial of antioxidant vitamins, 5442 women who were US health professionals aged 42 years or older

JAMA2008 Full Text: Link to full Text with Trip Pro

59. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial.

Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. 18984888 2008 11 05 2008 11 10 2016 12 15 1538-3598 300 17 2008 Nov 05 JAMA JAMA Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. 2012-21 10.1001/jama.2008.555 Folate, vitamin B(6), and vitamin B(12) are thought to play an important role in cancer prevention. To evaluate the effect of combined folic acid, vitamin B(6), and vitamin B(12 (...) ) treatment on cancer risk in women at high risk for cardiovascular disease. In the Women's Antioxidant and Folic Acid Cardiovascular Study, 5442 US female health professionals aged 42 years or older, with preexisting cardiovascular disease or 3 or more coronary risk factors, were randomly assigned to receive either a daily combination of folic acid, vitamin B(6), and vitamin B(12) or a matching placebo. They were treated for 7.3 years from April 1998 through July 31, 2005. Daily supplementation

JAMA2008 Full Text: Link to full Text with Trip Pro

60. Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction

Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password (...) ? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction Article Text Therapeutics Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction Statistics from Altmetric.com

Evidence-Based Medicine (Requires free registration)2007